STOP (Screen, Treat, Overcome, Prevent) HIV in LGBT Seniors

STOP (Screen, Treat, Overcome, Prevent) HIV in LGBT Seniors is organized by DKBmed. This Online CME Course will be held on Dec 10, 2020 as a live webinar.

Target Audience:
This CME activity has been designed to meet the educational requirements of clinicians committed in the care of patients with HIV or at risk for HIV.

Accreditation:
Physician Continuing Medical Education:
The Postgraduate Institute for Medicine assigns this CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians will be able to earn the credit commensurate based on the extent of their participation in the activity.

Successful completion of this CME activity, which involves participation in the evaluation component, allowing the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Respondents will obtain MOC points commensurate to the amount of CME credits claimed for the activity. It is the responsibility of a CME activity provider to submit participant completion information to ACCME with an intent to grant ABIM MOC credit.

AAPA Credit Designation Statement - Enduring Materials:
Postgraduate Institute for Medicine has been approved by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is assigned for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Continuing Nursing Education:
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

49% of people living with HIV are over age 50, with one-third of people living with HIV older than 55.

The aging HIV population requires special consideration. In addition to the “normal” stresses of aging, such as social isolation, older people living with HIV face the dual threat of ageism and HIV stigma. Clinicians need to understand this population in order to better treat them. Together we can STOP (Screen, Treat, Overcome, Prevent) HIV.

Topics covered: 
• Should you screen your senior patients for HIV? 
• What is pre-exposure prophylaxis (PrEP) and who needs it? 
• Special circumstances when treating older adults with HIV including stigma, comorbid conditions, and pharmacotherapy.
• Pros and cons of switching virally suppressed patients to regimens with lower side effect profiles and simpler dosing. 

Educational Objectives:
At the conclusion of this online activity, the participant should be better able to:
• Recognize patients who should be screened for HIV at appropriate intervals.
• Evaluate eligibility for PrEP among patients seen in your practice.
• Evaluate factors associated with the aging population, such as social stigma and polypharmacy, that may complicate HIV treatment or warrant special considerations.
• Appraise data concerning safety and efficacy of switching virally suppressed patients to medications with a lower risk of side effects or drug interactions or those with simpler dosing/administration requirements.